Trials / Completed
CompletedNCT02485275
Stroke Imaging Package Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 949 (actual)
- Sponsor
- Wei-Hai Xu · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Our study aims to explore the value of new imaging technique package in predicting early neurological deterioration (END) as well as 90-day unfavorable outcome in patients with acute ischaemic stroke.
Detailed description
1. Patients with acute ischemic stroke within 4.5-72h after onset were prospectively enrolled in our study and underwent standardized clinical and new imaging technique package assessment. 2. New imaging technique package mainly includes conventional cranial MRI (T1,T2,T2 FLAIR,DWI, and ADC), cranial magnetic resonance angiography (MRA), and intracranial vessel wall imaging (High-Resolution Magnetic Resonance Imaging,HRMRI) as well as susceptibility weighted imaging (SWI). 3. The neurofunctional fluctuation during hospitalization as well as 90-day outcomes were carefully assessed. Patients were followed up for 90-days after stroke onset. 4. Our study aims to explore the value of new imaging technique package in predicting early neurological deterioration (END) as well as 90-day unfavorable outcome in patients with acute ischaemic stroke.
Conditions
Timeline
- Start date
- 2015-07-01
- Primary completion
- 2017-04-30
- Completion
- 2017-11-30
- First posted
- 2015-06-30
- Last updated
- 2018-12-14
Locations
16 sites across 1 country: China
Source: ClinicalTrials.gov record NCT02485275. Inclusion in this directory is not an endorsement.